In this interview, we had the pleasure of speaking with Robert Fox about biomarker discovery and development in multiple sclerosis, including serum neurofilament light.
In this interview, we spoke with Justin Lathia about sexual dimorphism in glioblastoma, including his talk on sex differences in microglia and the glioma microenvironment.
Whilst at SfN 2018, we had the pleasure of speaking with Subhash Kulkarni about advances in enteric neurobiology, including challenges and future outlook.
At ECTRIMS, we had the pleasure of speaking with Marianna Cortese about her research in multiple sclerosis, including her interest in the microbiome.
In this interview, we spoke with Bruce Trapp about how his team identified a new subtype of multiple sclerosis, termed myelocortical multiple sclerosis.
At AAIC 2018, we had the pleasure of speaking with Catherine Kaczorowski about the innovative work she is doing to accelerate drug discovery in Alzheimer’s disease.
Whilst at AAIC 2018, we spoke with Tom Russ about life course air pollution exposure and the significance of this on neurological disorders.
In this interview, we spoke with Giovanni Frisoni about his talk on gut microbiome alterations and what impact this research could have for patients.
In this interview, we spoke with Guido Bertolini about the first results from the CREACTIVE trial on circulating biomarkers in traumatic brain injury.
Whilst at FENS 2018, we spoke with Arnold Kriegstein on his work with cerebral organoids in brain development, and how we might define a cell’s maturity.